Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals
Corresponding Author
Koert Gooijer
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Correspondence:
Koert Gooijer, Research Physican, Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.
E-mail: [email protected]
Search for more papers by this authorJan M. M. Rondeel
Department of Clinical Chemistry, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorFleur S. van Dijk
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
North West Thames Regional Genetics Service, Ehlers-Danlos Syndrome National Diagnostic Service London, North West Health Care University NHS Trust, Harrow, Middlesex, UK
Search for more papers by this authorArjan G. J. Harsevoort
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorGuus J. M. Janus
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorAnton A. M. Franken
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorCorresponding Author
Koert Gooijer
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Correspondence:
Koert Gooijer, Research Physican, Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.
E-mail: [email protected]
Search for more papers by this authorJan M. M. Rondeel
Department of Clinical Chemistry, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorFleur S. van Dijk
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
North West Thames Regional Genetics Service, Ehlers-Danlos Syndrome National Diagnostic Service London, North West Health Care University NHS Trust, Harrow, Middlesex, UK
Search for more papers by this authorArjan G. J. Harsevoort
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorGuus J. M. Janus
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorAnton A. M. Franken
Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands
Search for more papers by this authorSummary
Osteogenesis imperfecta (OI) is characterized by susceptibility to bone fractures. Other symptoms, such as easy bruising and bleeding complications during surgery necessitating transfusions, have also been reported. The aim of the cross-sectional pilot study was to assess the bleeding and bruising tendency in OI patients and to screen for possible underlying haematological disorders. Bleeding tendency was investigated using the International Society on Thrombosis and Haemostasis bleeding assessment tool (ISTH-BAT) in 22 adult OI patients. Laboratory testing was performed to investigate for bleeding disorders or abnormal coagulation. Four patients [OI type 1(n = 3), OI type 4(n = 1)] had a bleeding score (BS) fitting with a bleeding tendency, but without test results pointing to a coagulopathy. Two patients [OI type 1(n = 1), OI type 3 (n = 1)] without a bleeding tendency according to the BS had increased fibrinolysis. This is the second largest study to date addressing bleeding tendency in OI and the first study to use ISTH-BAT and elaborate laboratory testing for coagulopathies. Four patients had an increased bleeding tendency. However, laboratory testing demonstrated no bleeding disorder or abnormal coagulation. Increased fibrinolysis was demonstrated in two patients without bleeding tendency on BS. Vascular fragility as a cause of bleeding tendency in OI has been suggested earlier. Further research on bleeding tendency in OI is important.
Disclosure
The authors have stated that they have nothing to disclose and have no conflicts of interest.
References
- Akkerman, J.W.N. (2006) Betekenis van de ‘ Platelet Function Analyzer-100 ® ’ in de dagelijkse diagnostiek. Nederlands Tijdschrift voor Hematologie, 3, 133–137.
- Alves, G.S.A., Orsi, F.A., Santiago-Bassora, F.D., Quaino, S.K.P., Montalvão, S.A.L., de Paula, E.V. & Annichino-Bizzacchi, J.M. (2016) Laboratory evaluation of patients with undiagnosed bleeding disorders. Blood Coagulation & Fibrinolysis, 27, 500–505.
- Castellone, D.D. (2017) Establishing reference intervals in the coagulation laboratory. International Journal of Laboratory Hematology, 39, 121–127.
- CLSI. (2008). Defining, establishing, and verifying reference intervals in the clinical laboratory; Approved Guideline—Third Edition. CLSI document EP28-A3c. Clinical and Laboratory Standards Institute, Wayne, PA.
- Deforest, M., Grabell, J., Albert, S., Young, J., Tuttle, A., Hopman, W.M. & James, P.D. (2015) Generation and optimization of the self-administered bleeding assessment tool and its validation as a screening test for von Willebrand disease. Haemophilia, 21, e384–e388.
- Dunnen, J.T., Dalgleish, R., Maglott, D.R., Hart, R.K., Greenblatt, M.S., McGowan-Jordan, J., Roux, A., Smith, T., Antonarakis, S.E. & Taschner, P.E. (2016) HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Human Mutation, 37, 564–569.
- Edge, G., Okafor, B., Fennelly, M.E. & Ransford, A.O. (1997) An unusual manifestation of bleeding diathesis in a patient with osteogenesis imperfecta. European journal of anaesthesiology, 14, 215–219.
- Elbatarny, M., Mollah, S., Grabell, J., Bae, S., Deforest, M., Tuttle, A., Hopman, W., Clark, D.S., Mauer, A.C., Bowman, M., Riddel, J., Christopherson, P.A., Montgomery, R.R., Rand, M.L., Coller, B. & James, P.D. (2014) Normal range of bleeding scores for the ISTH-BAT: Adult and pediatric data from the merging project. Haemophilia, 20, 831–835.
- CLSI. 2010. EP28-A3c defining, establishing, and verifying reference intervals in the clinical laboratory; Approved Guideline—Third Edition. Wayne, PA: Clinical and Laboratory Standards Institute. (ISBN1-56238-682-4)
- Estes, J.W. (1968) Platelet size and function in the heritable disorders of connective tissue. Annals of internal medicine, 68, 1237–1249.
- Evensen, S.A., Myhre, L. & Stormorken, H. (1984) Haemostatic studies in osteogenesis imperfecta. Scandinavian Journal of Haematology, 33, 177–179.
- Faqeih, E., Roughley, P., Glorieux, F.H. & Rauch, F. (2009) Osteogenesis imperfecta type III with intracranial hemorrhage and brachydactyly associated with mutations in exon 49 of COL1A2. American Journal of Medical Genetics Part A, 149A, 461–465.
- Goddeau, R.P., Caplan, L.R. & Alhazzani, A.A. (2010) Intraparenchymal hemorrhage in a patient with osteogenesis imperfecta and plasminogen activator inhibitor-1 deficiency. Archives of Neurology, 67, 236–238.
- Hathaway, W.E., Solomons, C.C. & Ott, J.E. (1972) Platelet function and pyrophosphates in osteogenesis imperfecta. Blood, 39, 500–509.
- Hayward, C.P.M. (2018). How I investigate for bleeding disorders. International Journal of Laboratory Hematology, 40, 6–14.
- Jin, G., Aobulikasimu, A., Piao, J., Aibibula, Z., Koga, D., Sato, S., Ochi, H., Tsuji, K., Nakabayashi, T., Miyata, T., Okawa, A. & Asou, Y. (2018) A small-molecule PAI-1 inhibitor prevents bone loss by stimulating bone formation in a murine estrogen deficiency-induced osteoporosis model. FEBS Open Bio, 8, 523–532.
- Karnofsky, D. & Burchenal, J. (1948) The clinical evaluation of chemotherapeutic agents in cancer. In: Evaluation of chemotherapeutic agents (ed. by C.M. MacLeod), pp. 191–205. Columbia University Press, New York.
- Kastrup, M., von Heymann, C., Hotz, H., Konertz, W.F., Ziemer, S., Kox, W.J. & Spies, C. (2002) Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta. The Annals of thoracic surgery, 74, 910–912.
- Lowe, G.C., Lordkipanidzé, M. & Watson, S.P. (2013) Utility of the ISTH bleeding assessment tool in predicting platelet defects in participants with suspected inherited platelet function disorders. Journal of Thrombosis and Haemostasis, 11, 1663–1668.
- Mao, L., Kawao, N., Tamura, Y., Okumoto, K., Okada, K., Yano, M., Matsuo, O. & Kaji, H. (2014) Plasminogen activator inhibitor-1 is involved in impaired bone repair associated with diabetes in female mice. PLoS ONE, 9, 3–10.
- Marini, J.C., Forlino, A., Cabral, W.A., Barnes, A.M., San Antonio, J.D., Milgrom, S., Hyland, J.C., Körkkö, J., Prockop, D.J., De Paepe, A., Coucke, P., Symoens, S., Glorieux, F.H., Roughley, P.J., Lund, A.M., Kuurila-Svahn, K., Hartikka, H., Cohn, D.H., Krakow, D., Mottes, M., Schwarze, U., Chen, D., Yang, K., Kuslich, C., Troendle, J., Dalgleish, R. & Byers, P.H. (2007) Consortium for osteogenesis imperfecta mutations in the helical domain of type I collagen: Regions rich in lethal mutations align with collagen binding sites for integrins and proteoglycans. Human Mutation, 28, 209–221.
- Mayer, S.A., Rubin, B.S., Starman, B.J. & Byers, P.H. (1996) Spontaneous multivessel cervical artery dissection in a patient with a substitution of alanine for glycine (G13A) in the α1(I) chain of type I collagen. Neurology, 47, 552–556.
- McAllion, S.J. & Paterson, C.R. (1996) Causes of death in osteogenesis imperfecta. Journal of clinical pathology, 49, 627–30.
- Mondai, R.K., Mann, U., Sharma, M., Mondal, R.K., Mann, U. & Sharma, M. (2003) Osteogenesis imperfecta with bleeding diathesis. Indian Journal of Pediatrics, 70, 95–96.
- Moritake, A., Kawao, N., Okada, K., Tatsumi, K., Ishida, M., Okumoto, K., Matsuo, O., Akagi, M. & Kaji, H. (2017) Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice. BMC Musculoskeletal Disorders, 18, 392.
- Ozarda, Y., Higgins, V. & Adeli, K. (2018) Verification of reference intervals in routine clinical laboratories: practical challenges and recommendations. Clinical Chemistry and Laboratory Medicine (CCLM), 57, 30–37.
- Paterson, C.R. & Monk, E.A. (2013) Temporary brittle bone disease: association with intracranial bleeding. Journal of Pediatric Endocrinology and Metabolism, 26, 417–26.
- Persiani, P., Pesce, M.V., Martini, L., Ranaldi, F.M., D’Eufemia, P., Zambrano, A., Celli, M. & Villani, C. (2018) Intraoperative bleeding in patients with osteogenesis imperfecta type III treated by Fassier-Duval femoral rodding: analysis of risk factors. Journal of Pediatric Orthopaedics B, 27, 338–343.
- Rodeghiero, F., Tosetto, A., Abshire, T., Arnold, D., Coller, B., James, P.D., Neunert, C. & Lillicrap, D. (2011) ISTH BAT: Supplementary material to the official communication of the SSC. Journal of Thrombosis and Haemostasis, 8, 1–21.
- Sadler, J.E. (2003) Von Willebrand disease type 1: A diagnosis in search of a disease. Blood, 101, 2089–2093.
- Schmider, E., Ziegler, M., Danay, E., Beyer, L. & Bühner, M. (2010) Is It Really Robust? Reinvestigating the robustness of ANOVA against violations of the normal distribution assumption. Methodology, 6, 147–151.
- Schvartz, I., Seger, D. & Shaltiel, S. (1999) Vitronectin. The International Journal of Biochemistry & Cell Biology, 31, 539–544.
- Siegel, B.M., Friedman, I.A. & Schwartz, S.O. (1957) Hemorrhagic disease in osteogenesis imperfecta study of platelet functional defect. The American Journal of Medicine, 22, 315–321.
- Starr, S.R., Roberts, T.T. & Fischer, P.R. (2010) Osteogenesis imperfecta: Primary care. Pediatrics in Review, 31, e54–e64.
- Steiner, R., Adsit, J. & Basel, D. (2013) COL1A1/2-Related Osteogenesis Imperfecta. [Updated 2013 Feb 14]. In: GeneReviews® [Internet] (ed. by M.P. Adam, H.H. Ardinger, R.A. Pagon, et al.), pp. 1993–2019. University of Washington, Seattle, Seattle, WA.
- Tosetto, A., Castaman, G., Plug, I., Rodeghiero, F. & Eikenboom, J. (2011) Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation. Journal of Thrombosis and Haemostasis, 9, 1143–1148.
- Van Dijk, F.S. & Sillence, D.O. (2014) Osteogenesis imperfecta: Clinical diagnosis, nomenclature and severity assessment. American Journal of Medical Genetics, Part A, 164, 1470–1481.